Rijnders BJA - Search Results

1

Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort Study.

Vasylyev M, Wit FWNM, Jordans CCE, Soetekouw R, van Lelyveld SFL, Kootstra GJ, Delsing CE, Ammerlaan HSM, van Kasteren MEE, Brouwer AE, Leyten EMS, Claassen MAA, Hassing RJ, den Hollander JG, van den Berge M, Roukens AHE, Bierman WFW, Groeneveld PHP, Lowe SH, van Welzen BJ, Richel O, Nellen JF, van den Berk GEL, van der Valk M, Rijnders BJA, Rokx C. Vasylyev M, et al. Among authors: rijnders bja. Open Forum Infect Dis. 2024 Mar 18;11(4):ofae160. doi: 10.1093/ofid/ofae160. eCollection 2024 Apr. Open Forum Infect Dis. 2024. PMID: 38567196 Free PMC article. Clinical Trial.

2

Incidence of voriconazole hepatotoxicity during intravenous and oral treatment for invasive fungal infections.

den Hollander JG, van Arkel C, Rijnders BJ, Lugtenburg PJ, de Marie S, Levin MD. den Hollander JG, et al. J Antimicrob Chemother. 2006 Jun;57(6):1248-50. doi: 10.1093/jac/dkl108. Epub 2006 Mar 23. J Antimicrob Chemother. 2006. PMID: 16556632

3

Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort.

van Lelyveld SF, Gras L, Kesselring A, Zhang S, De Wolf F, Wensing AM, Hoepelman AI; ATHENA national observational cohort study. van Lelyveld SF, et al. AIDS. 2012 Feb 20;26(4):465-74. doi: 10.1097/QAD.0b013e32834f32f8. AIDS. 2012. PMID: 22112603

4

Peginterferon alfa-2a for AIDS-associated Kaposi sarcoma: experience with 10 patients.

Rokx C, van der Ende ME, Verbon A, Rijnders BJ. Rokx C, et al. Clin Infect Dis. 2013 Nov;57(10):1497-9. doi: 10.1093/cid/cit517. Epub 2013 Aug 2. Clin Infect Dis. 2013. PMID: 23912848

5

The efficacy, pharmacokinetics, and safety of a nevirapine to rilpivirine switch in virologically suppressed HIV-1-infected patients.

Rokx C, Blonk M, Verbon A, Burger D, Rijnders BJ. Rokx C, et al. J Acquir Immune Defic Syndr. 2015 Jan 1;68(1):36-9. doi: 10.1097/QAI.0000000000000363. J Acquir Immune Defic Syndr. 2015. PMID: 25247434 Clinical Trial.

6

Increased virological failure in naive HIV-1-infected patients taking lamivudine compared with emtricitabine in combination with tenofovir and efavirenz or nevirapine in the Dutch nationwide ATHENA cohort.

Rokx C, Fibriani A, van de Vijver DA, Verbon A, Schutten M, Gras L, Rijnders BJ; AIDS Therapy Evaluation in the Netherlands National Observational Cohort. Rokx C, et al. Clin Infect Dis. 2015 Jan 1;60(1):143-53. doi: 10.1093/cid/ciu763. Epub 2014 Oct 1. Clin Infect Dis. 2015. PMID: 25273080

7

More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV Cohort.

Rokx C, Fibriani A, van de Vijver D, Verbon A, Schutten M, Gras L, Rijnders BJ. Rokx C, et al. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19491. doi: 10.7448/IAS.17.4.19491. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25394000 Free PMC article.

8

The efficacy, pharmacokinetics, safety and cardiovascular risks of switching nevirapine to rilpivirine in HIV-1 patients: the RPV switch study.

Rokx C, Blonk M, Verbon A, Burger D, Rijnders BJ. Rokx C, et al. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19789. doi: 10.7448/IAS.17.4.19789. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397533 Free PMC article.

9

Diminished impact of ethnicity as a risk factor for chronic kidney disease in the current HIV treatment era.

Schoffelen AF, Smit C, van Lelyveld SF, Vogt L, Bauer MP, Reiss P, Hoepelman AI, Barth RE; ATHENA National Observational HIV Cohort. Schoffelen AF, et al. J Infect Dis. 2015 Jul 15;212(2):264-74. doi: 10.1093/infdis/jiv026. Epub 2015 Jan 18. J Infect Dis. 2015. PMID: 25601941

10

Short communication: Lipids and cardiovascular risk after switching HIV-1 patients on nevirapine and emtricitabine/tenofovir-DF to rilpivirine/emtricitabine/tenofovir-DF.

Rokx C, Verbon A, Rijnders BJ. Rokx C, et al. AIDS Res Hum Retroviruses. 2015 Apr;31(4):363-7. doi: 10.1089/AID.2014.0278. Epub 2015 Feb 26. AIDS Res Hum Retroviruses. 2015. PMID: 25625211 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters